March 7 (Reuters) - Geneuro SA GNRO.PA :
* THE EIB AND GENEURO SIGN A EUR 25 MILLION CREDIT LINE
BACKED BY
INVESTEU TO SUPPORT CLINICAL DEVELOPMENTS AGAINST LONG-COVID
* EXTENSION OF GENEURO'S CASH VISIBILITY TO 3Q2024,
INCLUDING
FIRST TRANCHE OF EUR 7 MILLION.
* FIRST TRANCHE OF EUR 7MILLION, AVAILABLE IMMEDIATELY, IS
INTENDED TO SUPPORT PHASE 2 CLINICAL TRIAL IN LONG-COVID
* OTHER TRANCHES OF EUR10 MILLION AND EUR8 MILLION ARE
INTENDED
FOR PREPARATION AND LAUNCH OF PHASE 3 RESPECTIVELY
Source text for Eikon: ID:nBw8bcTQka
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))